Walleye Trading »

Abcellera Biologics shares owned by Walleye Trading

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Walleye Trading from 13F filings

Historical chart of Walleye Trading investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Walleye Trading consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Walleye Trading

Quarter filed Position value Share count Share price at filing
2023-12-31 $96k 17k 5.71
2023-09-30 $138k 30k 4.60
2023-06-30 $372k 58k 6.46
2023-03-31 $196k 26k 7.54
2022-09-30 $1.2M 124k 9.89

More positions owned by Walleye Trading

Spdr S&p 500 Etf Tr Tr Unit Put Option (SPY)
NVIDIA Corporation Put Option (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Meta Platforms Cl A (META)
Advanced Micro Devices Call Option (AMD)
Microsoft Corporation Call Option (MSFT)
Apple (AAPL)
Amazon (AMZN)
Tesla Motors Put Option (TSLA)
Intel Corporation Call Option (INTC)
Pdd Holdings Sponsored Ads Call Option (PDD)
Palo Alto Networks Put Option (PANW)
Alibaba Group Hldg Sponsored Ads (BABA)
Crowdstrike Hldgs Cl A Put Option (CRWD)

View all positions for Walleye Trading

Top funds holding Abcellera Biologics

Baillie Gifford & Co
Baker Bros. Advisors
Credit Suisse
OrbiMed Advisors
Arrowpoint Asset Management
Founders Fund VII Management
Lazard Asset Management
Federated Investors
Casdin Capital
Guardian Capital Advisors
Millennium Management
Two Sigma Investments
Citadel Advisors
Two Sigma Advisers
Norges Bank Investment Management

View all funds holding Abcellera Biologics